An evaluative in vitro investigation of the delivery of cytarabine with RGD decorated solid lipid nanoparticles

References

• Adams, F.C. and Barbante, C., 2013. Nanoscience, nanotechnology and spectrometry. Spectrochimica acta part B: atomic spectroscopy, 86, 3–13.
   Web of Science ®Google Scholar
• Akbal, Ö., et al., 2017. Comparison of protein- and polysaccharide-based nanoparticles for cancer therapy: synthesis, characterization, drug release, and interaction with a breast cancer cell line. Artificial cells, nanomedicine, and biotechnology, 45 (2), 193–203. DOI:https://doi.org/10.3109/21691401.2016.1170694.
   PubMed Web of Science ®Google Scholar
• Al-Amin, M., et al., 2016. Increased therapeutic efficacy of a newly synthesized tyrosinase inhibitor by solid lipid nanoparticles in the topical treatment of hyperpigmentation. Drug design, development and therapy, 10, 3947–3957.
   PubMed Web of Science ®Google Scholar
• Aldawsari, H.M. and Singh, S., 2020. Rapid microwave-assisted cisplatin-loaded solid lipid nanoparticles: synthesis, characterization and anticancer study. Nanomaterials, 10 (3), 510.
   Web of Science ®Google Scholar
• Alipour, M., et al., 2020. Recent progress in biomedical applications of RGD-based ligand: from precise cancer theranostics to biomaterial engineering: a systematic review. Journal of biomedical materials research. Part A, 108 (4), 839–850.
   PubMed Web of Science ®Google Scholar
• Asasutjarit, R., et al., 2007. Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro pHIS-HIV-hugag transfection. Pharmaceutical research, 24 (6), 1098–1107.
   PubMed Web of Science ®Google Scholar
• Bandari, S., et al., 2010. Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for fenoverine. Acta pharmaceutica, 60 (1), 89–97.
   PubMed Web of Science ®Google Scholar
• Bangale, G.S., Shinde, G., and KS, R., 2019. Formulation and optimization of nanoparticale by 32 factorial design for colon targeting. Global journal of pharmacy & pharmaceutical sciences, 7 (1).
   Google Scholar
• Bao, H., et al., 2020. Synergistic effect of tangeretin and atorvastatin for colon cancer combination therapy: targeted delivery of these dual drugs using RGD peptide decorated nanocarriers. Drug design, development and therapy, 14, 3057–3068.
   PubMed Web of Science ®Google Scholar
• Chantaburanan, T., et al., 2017. Effect of binary solid lipid matrix of wax and triglyceride on lipid crystallinity, drug-lipid interaction and drug release of ibuprofen-loaded solid lipid nanoparticles (SLN) for dermal delivery. Journal of colloid and interface science, 504, 247–256.
   PubMed Web of Science ®Google Scholar
• Demirbilek, M., et al., 2017. VitD3-loaded solid lipid nanoparticles: stability, cytotoxicity and cytokine levels. Journal of microencapsulation, 34 (5), 454–462.
   PubMed Web of Science ®Google Scholar
• Doktorovova, S., Souto, E.B., and Silva, A.M., 2014. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – a systematic review of in vitro data. European journal of pharmaceutics and biopharmaceutics, 87 (1), 1–18.
   PubMed Web of Science ®Google Scholar
• Garanti, T., Alhnan, M.A., and Wan, K.W., 2020. RGD-decorated solid lipid nanoparticles enhance tumor targeting, penetration and anticancer effect of asiatic acid. Nanomedicine, 15 (16), 1567–1583.
   PubMed Web of Science ®Google Scholar
• Garg, A., et al., 2017. In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles. International journal of pharmaceutics, 516 (1–2), 120–130.
   PubMed Web of Science ®Google Scholar
• Ghaji, M.S., and Zakaria, Z.A.B., 2018. Novel synthesis of nanoparticles from cockle shells via mechanical method for cytarabine drug release. Journal of computational and theoretical nanoscience, 15 (4), 1128–1136.
   Google Scholar
• Ginsburg, G., and Phillips, K.A., 2018. Precision medicine: From science to value. Health affairs, 37 (5).
   Web of Science ®Google Scholar
• Heo, S.-K., et al., 2020. Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death. BMC cancer, 20, 1193.
   Google Scholar
• Hosseini, S.M., et al., 2019. Doxycycline-encapsulated solid lipid nanoparticles as promising tool against Brucella melitensis enclosed in macrophage: a pharmacodynamics study on J774A.1 cell line. Antimicrobial resistance and infection control, 8 (1), 62.
   PubMed Web of Science ®Google Scholar
• Iso, I., 2009. 10993–5: 2009 Biological evaluation of medical devices—part 5: tests for in vitro cytotoxicity. Geneva: International Organization for Standardization.
   Google Scholar
• Jabbour, E., et al., 2007. Current and emerging treatment options in chronic myeloid leukemia. Cancer, 109 (11), 2171–2181.
   PubMed Web of Science ®Google Scholar
• Jain, A., et al., 2015. Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin. Colloids Surf B Biointerfaces, 134, 47–58.
   PubMed Web of Science ®Google Scholar
• Josan, J.S., et al 2011. Cell-specific targeting by heterobivalent ligands. Bioconjugate chemistry, 22 (7), 1270–1278.
   PubMed Web of Science ®Google Scholar
• Joshy, K.S., et al., 2020. NiFe 2 O 4/poly(ethylene glycol)/lipid–polymer hybrid nanoparticles for anti-cancer drug delivery. New journal of chemistry, 44 (42), 18162–18172.
   Web of Science ®Google Scholar
• Kalaycioglu, G.D. and Aydogan, N., 2016. Preparation and investigation of solid lipid nanoparticles for drug delivery. Colloids and surfaces A: Physicochemical and engineering aspects, 510, 77–86.
   Web of Science ®Google Scholar
• Kaur, P., et al., 2014. Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design. Drug delivery, 23 (6), 1–14.
   PubMed Web of Science ®Google Scholar
• Kavaz, D., et al., 2021. Biosynthesized ZnO nanoparticles using albizia lebbeck extract induced biochemical and morphological alterations in wistar rats. Molecules, 26 (13), 3864.
   PubMed Web of Science ®Google Scholar
• Kavaz, D., Idris, M., and Onyebuchi, C., 2019. Physiochemical characterization, antioxidative, anticancer cells proliferation and food pathogens antibacterial activity of chitosan nanoparticles loaded with Cyperus articulatus rhizome essential oils. International journal of biological macromolecules, 123, 837–845.
   PubMed Web of Science ®Google Scholar
• Kavaz, D., Umar, H., and Shehu, S., 2018. Synthesis, characterization, antimicrobial and antimetastatic activity of silver nanoparticles synthesized from Ficus ingens leaf. Artificial cells, nanomedicine, and biotechnology, 46 (sup3), S1193–S1203. DOI:https://doi.org/10.1080/21691401.2018.1536060.
   PubMed Web of Science ®Google Scholar
• Kumar, S. and Randhawa, J.K., 2015. Solid lipid nanoparticles of stearic acid for the drug delivery of paliperidone. RSC advances, 5 (84), 68743–68750.
   Web of Science ®Google Scholar
• Lingayat, V.J., Zarekar, N.S., and Shendge, R.S., 2017. Solid lipid nanoparticles: a review. Nanoscience and nanotechnology research, 4 (2), 67–72.
   Google Scholar
• Liu, R., et al., 2018. Self-assembling nanoparticles based on cytarabine prodrug for enhanced leukemia treatment. Journal of molecular liquids, 251, 178–184.
   Web of Science ®Google Scholar
• Liu, Z., Wang, F., and Chen, X., 2008. Integrin αvβ3-targeted cancer therapy. Drug development research, 69 (6), 329–339.
   PubMed Web of Science ®Google Scholar
• Lowell, C.A., and Mayadas, T.N., 2012. Overview: studying integrins in vivo. Methods in molecular biology (clifton, N.J.), 757, 369–397.
   PubMedGoogle Scholar
• Madni, A., et al., 2017. Drug-polymer interaction studies of cytarabine-loaded chitosan nanoparticles. Chemical society of Pakistan, 39 (06), 1045–1054. https://www.researchgate.net/publication/321997744
   Google Scholar
• Mahmoudi, R., et al., 2021. RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells. Journal of biomaterials applications, 35 (7), 743–753.
   PubMed Web of Science ®Google Scholar
• Müller, R.H., Rühl, D., and Runge, S.A., 1996. Biodegradation of solid lipid nanoparticles as a function of lipase incubation time. International journal of pharmaceutics, 144 (1), 115–121.
   Web of Science ®Google Scholar
• Nounou, M.I., et al., 2015. Breast cancer: conventional diagnosis and treatment modalities and recent patents and technologies supplementary issue: targeted therapies in breast cancer treatment. Breast cancer: basic and clinical research, 9 (Suppl 2), 17–34.
   PubMedGoogle Scholar
• Onyebuchi, C. and Kavaz, D., 2019. Chitosan and N, N, N-trimethyl chitosan nanoparticle encapsulation of ocimum gratissimum essential oil: optimised synthesis, in vitro release and bioactivity >. International journal of nanomedicine, 14, 7707–7727.
   PubMed Web of Science ®Google Scholar
• Onyebuchi, C. and Kavaz, D., 2020. Effect of extraction temperature and solvent type on the bioactive potential of Ocimum gratissimum L. extracts. Scientific reports, 10 (1), ), Scientific reports, 10, 1–11.
   PubMed Web of Science ®Google Scholar
• Padmaa Paarakh, M., et al., 2018. Release kinetics-concepts and applications. | International journal of pharmacy research & technology, 8 (1), 12–20.
   Google Scholar
• Patil, J., et al., 2018. Preparation and characterization of artemether loaded solid lipid nanoparticles: a 32 factorial design approach. Materials technology, 35 (11–12), 719–726.
   Web of Science ®Google Scholar
• Qiang, Z., et al., 2017. Cite this article as. Chinese journal of analytical chemistry, 45 (5), 662–667.
   Google Scholar
• Rahimi, M., Mobedi, H., and Behnamghader, A., 2016. In situ-forming PLGA implants loaded with leuprolide acetate/β-cyclodextrin complexes: mathematical modelling and degradation. Journal of microencapsulation, 33 (4), 355–364. DOI:https://doi.org/10.1080/02652048.2016.1194905.
   PubMed Web of Science ®Google Scholar
• Raj, R., Raj, P.M., and Ram, A., 2016. Preparation and characterization of solid lipid nanoparticles loaded with cytarabine: via a micellar composition for leukemia. RSC advances, 6 (58), 53578–53586.
   Web of Science ®Google Scholar
• Ramteke, K.H., Joshi, S.A., and Dhole, S.N., 2012. Solid lipid nanoparticle: a review. IOSR journal of pharmacy, 2 (6), 33–34.
   Google Scholar
• Remington’s pharmaceutical sciences. 1976. Journal of pharmaceutical sciences. 65 (6), 933.
   Google Scholar
• Ritger, P.L. and Peppas, N.A., 1987. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. Journal of controlled release, 5 (1), 37–42.
   Google Scholar
• Salehi, B., et al., 2019. Liposomal cytarabine as cancer therapy: from chemistry to medicine. Biomolecules, 9 (12), 773.
   PubMed Web of Science ®Google Scholar
• Santos, D., et al., 2014. Synthesis and physico-chemical properties of two protic ionic liquids based on stearate anion. Fluid phase equilibria, 376, 132–140.
   Web of Science ®Google Scholar
• Sezigen, S., et al., 2020. In vitro evaluation of two different types of obidoxime-loaded nanoparticles for cytotoxicity and blood-brain barrier transport. Toxicology letters, 330, 53–58.
   PubMed Web of Science ®Google Scholar
• Siepmann, F., Le Brun, V., and Siepmann, J., 2006. Drugs acting as plasticizers in polymeric systems: a quantitative treatment. Journal of controlled release, 115 (3), 298–306.
   PubMed Web of Science ®Google Scholar
• Singh, A., et al., 2020. Encapsulation of cytarabine into casein coated iron oxide nanoparticles (CCIONPs) and study of in vitro drug release and anticancer activities. Journal of drug delivery science and technology, 55, 101396.
   Web of Science ®Google Scholar
• Souto, E.B., et al., 2019. Key production parameters for the development of solid lipid nanoparticles by high shear homogenization. Pharmaceutical development and technology, 24 (9), 1181–1185.
   PubMed Web of Science ®Google Scholar
• Trombino, S., et al., 2009. Stearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of beta-carotene and alpha-tocopherol . Colloids and surfaces. B, biointerfaces, 72 (2), 181–187.
   PubMed Web of Science ®Google Scholar
• Vellón, L., et al., 2010. Functional blockade of α5β1 integrin induces scattering and genomic landscape remodeling of hepatic progenitor cells. BMC cell biology, 11, 81.
   PubMedGoogle Scholar
• Von Wallbrunn, A., et al., 2007. In vivo imaging of integrin alpha v beta 3 expression using fluorescence-mediated tomography. European journal of nuclear medicine and molecular imaging, 34 (5), 745–754.
   PubMed Web of Science ®Google Scholar
• Wen, X., et al., 2018. Anticancer efficacy of targeted shikonin liposomes modified with RGD in breast cancer cells. Molecules, 23 (2), 268.
   PubMed Web of Science ®Google Scholar
• Wesley, N.O. and Moloto, M.J., 2019. Encapsulation of ibuprofen into solid lipid nanoparticles for controlled and sustained release using emulsification solvent evaporation technique. Asian journal of pharmaceutical and clinical research, 12 (8), 74–81.
   Google Scholar
• Winter, E., et al., 2016. Development and evaluation of lipid nanoparticles for drug delivery: study of toxicity in vitro and in vivo. Journal of nanoscience and nanotechnology, 16 (2), 1321–1330.
   PubMed Web of Science ®Google Scholar
• Wu, P.H., et al., 2017. Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells. International journal of nanomedicine, 12, 5069–5085.
   PubMed Web of Science ®Google Scholar
• Yang, X., et al., 2016. Nanoparticle-based topical ophthalmic gel formulation for sustained release of hydrocortisone butyrate. AAPS PharmSciTech, 17 (2), 294–306.
   PubMed Web of Science ®Google Scholar
• Yassemi, A., Kashanian, S., and Zhaleh, H., 2020. Folic acid receptor-targeted solid lipid nanoparticles to enhance cytotoxicity of letrozole through induction of caspase-3 dependent-apoptosis for breast cancer treatment. Pharmaceutical development and technology, 25 (4), 397–407.
   PubMed Web of Science ®Google Scholar
• Zhang, J.Q., et al., 2007. Preparation and characterization of solid lipid nanoparticles containing silibinin. Drug delivery, 14 (6), 381–387.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2018. Zero-order release of poorly water-soluble drug from polymeric films made via aqueous slurry casting. European journal of pharmaceutical sciences, 117, 245–254.
   PubMed Web of Science ®Google Scholar
• Zheng, G., et al., 2019. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo. Biomedicine & pharmacotherapy [ biomedecine & pharmacotherapie], 116, 109006.
   PubMed Web of Science ®Google Scholar
• Zhu, J., et al., 2016. Simple and green fabrication of a superhydrophobic surface by one-step immersion for continuous oil/water separation. The journal of physical chemistry. A, 120 (28), 5617–5623.
   PubMed Web of Science ®Google Scholar